Equities
FinancialsInvestment Banking and Brokerage Services
  • Price (EUR)45.10
  • Today's Change0.10 / 0.22%
  • Shares traded1.57k
  • 1 Year change+22.22%
  • Beta0.5397
Data delayed at least 15 minutes, as of Feb 17 2026 08:10 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Gimv NV is a Belgium-based investment company. The five segments of the Company are investment platforms: Consumer, Healthcare, Life sciences, Smart industries, Sustainable cities. The Consumer platform focuses on companies that respond to current and future consumer needs and preferences. In the Health and Care platform, the Company invests in biotechnology, medical technology, and service companies in the health & care sector. Through Smart Industries platform the Company invests in innovation and intelligent technologies. The Sustainable Cities platform focuses on construction & materials, energy and environment, transport, logistics and mobility, and industrial services. The Company invests as well, in third-party funds and infrastructure.

  • Revenue in EUR (TTM)400.80m
  • Net income in EUR201.06m
  • Incorporated1980
  • Employees94.00
  • Location
    Gimv NVKarel Oomsstraat 37ANTWERPEN 2018BelgiumBEL
  • Phone+32 32902100
  • Fax+32 32902105
  • Websitehttps://www.gimv.com/en
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
GIMB:BRU since
announced
Transaction
value
Novicare BVAnnounced28 Aug 202528 Aug 2025Announced2.73%--
Alpine Nederland BVDeal completed24 Jun 202524 Jun 2025Deal completed4.28%--
Ambulantis Bsw GmbHDeal completed05 May 202505 May 2025Deal completed11.22%--
The Spice Factory SADeal completed20 Feb 202520 Feb 2025Deal completed23.06%--
Data delayed at least 15 minutes, as of Feb 17 2026 08:10 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
BIP Investment Partners SA20.41m-569.09k347.81m----0.00001--17.04-0.1309-0.13094.6880.120.0572--1.49---0.1595-2.97-0.1601-3.0096.6448.12-2.79-77.45----0.00---35.87-30.19131.83-53.29-23.16-6.73
Compagnie Du Bois Sauvage SA335.38m-7.32m495.76m1.15k--1.0218.271.48-4.57-4.57207.82304.210.47143.236.87292,142.80-0.12062.93-0.14913.4756.4053.23-0.25589.071.191.310.18869.686.726.40-150.59---1.161.49
Tinc NV53.38m42.88m542.06m--9.820.887612.6410.151.141.141.4212.600.0935--42.07--7.51--7.81------80.32----16.160.0524--------------
Gimv NV400.80m201.06m1.66bn94.007.460.83488.134.136.036.0312.2253.900.1805--77.954,263,862.009.058.609.308.8895.5795.3250.1645.49--3.320.153845.0926.8527.650.8622----1.39
Tetragon Financial Group Ltd833.60m588.56m1.80bn570.002.010.3593--2.167.627.6210.8142.580.2702--40.001,863,962.0019.087.0519.727.2376.0969.8270.6060.35--26.740.089817.49116.455.30149.614.11---9.88
Van Lanschot Kempen NV614.32m126.29m2.12bn2.07k16.531.6312.432.762.972.9718.0430.18--------0.81980.6732--------17.6516.70------76.0526.5619.9611.327.2526.3024.84
Rolinco NV66.79m9.89m3.60bn0.0027.750.3027--53.872.372.3716.18218.960.0699--15.24--1.038.811.038.8288.3787.8314.80132.29--1.200.004.02174.8613.162.27-3.43---4.36
Cenergy Holdings SA2.01bn178.20m4.21bn3.63k22.955.4019.582.100.86430.86439.743.680.90153.433.86552,301.408.014.3019.0910.6617.2812.898.884.690.66795.050.468111.9210.3713.4091.0747.1735.49--
Kbc Ancora NV323.14m315.86m5.85bn--18.511.62--18.114.114.114.2146.790.0877------8.5812.888.5813.0298.7397.4697.75124.04--168,909.400.027146.62-14.6333.01-14.3538.97----
Robeco Global Stars Equities Fund NV81.52m45.86m6.63bn--100.221.02--81.360.82710.82711.6980.980.0202--2.78--1.1314.141.1314.1956.2594.3156.2594.31----0.0010.8460.576.3162.166.23----
Data as of Feb 17 2026. Currency figures normalised to Gimv NV's reporting currency: Euro EUR

Institutional shareholders

8.01%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 04 Feb 2026914.69k2.49%
Dimensional Fund Advisors LPas of 31 Jan 2026622.45k1.69%
Norges Bank Investment Managementas of 30 Jun 2025544.62k1.48%
BlackRock Advisors (UK) Ltd.as of 06 Feb 2026186.47k0.51%
Candriam Belgium SAas of 31 Dec 2025151.10k0.41%
BlackRock Fund Advisorsas of 06 Feb 2026149.76k0.41%
Robeco Institutional Asset Management BVas of 31 Dec 2025110.45k0.30%
National Bank Trust, Inc.as of 06 Feb 202696.53k0.26%
Value Square NVas of 29 Jan 202689.76k0.24%
Invesco Capital Management LLCas of 06 Feb 202682.18k0.22%
More ▼
Data from 30 Sep 2025 - 29 Jan 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.